Allergan, Inc.

Atrix Laboratories, Inc.

Tolmar Therapeutics, Inc.

Qlt Usa, Inc.

John Steven Garrett

Richard L Dunn

Bhagya L Chandrashekar

Harish Ravivarapu

The methods described herein provide treatment of rosacea using topical formulations of dapsone. The methods also provide treatment of rosacea with topical dapsone in combination with other active agents, including metronidazole. The methods avoid negative hematologic side effects, including hemolysis and hemolytic anemia, that are associated with oral administration of dapsone.

Dapsone to treat rosacea

The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.

Polymeric delivery formulations of leuprolide with improved efficacy

Dapsone to treat rosascea

Growing community of inventors

Fort Collins, CO, United States of America

John Steven Garrett